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ABSTRACT   
 This study was carried out to evaluate the protective effects of autogenous bacterin against Vibrio cholerae 
ETOR type isolated from Ubahudara and Aruolah streams in Uli community, Ihiala L.G.A, Anambra State.  A 
total of 16 water samples were drawn from each stream and screened for the presence of Vibrio cholerae using 
pour plate method. The colonies generated from the primary isolation wassub cultured, characterized and 
identified using their colony description, morphological and biochemical characteristics. The pathogenic 
potentials of the organism on mice were investigated by challenging the mice orally using 0.5 ml of the inoculum 
(108cells/ml). The infected mice were kept under observation for two weeks for clinical signs, mortalities, gross 
lesions, histopathological changes and re-isolation from the internal organs after sacrificing the mice. The 
protective effect of bacterin was investigated using in vivo method. The result revealed that Vibrio cholerae 
ETOR type was significantly (P˂ 0.05) seen more in Ubahudara stream (67.44%) than Aruolah stream (32.56%). 
There were gross clinical abnormalities; kidney and liver congestion, perihepatits and fluid accumulation in the 
intestines. The histopathological examination revealed marked mono nuclear cell infilteration, disintegration of 
cartilage surrounding the bronchiole, necrosis of the tubules of kidney and red pulp of the spleen. The mean 
counts of the organism were significantly (P˂ 0.05) most in the lungs, followed by the spleen, kidney and the 
liver was the least. The results of in vivo activity showed that this autogenous bacterin was effective in reducing 
pathological changes. Its effect was significant (P˂ 0.05) when compared with the infected non-treated mice. 
Thus, this study has proven the efficacy of bacterin in preventing Vibrio cholerae ETOR type in albino mice for 
short term.  
Key words: Vibrio cholerae, autogenous, bacterin, histopathological 
INTRODUCTION 
  The name Vibrio was derived from Filippo Pacini, who isolated microorganism that he called “vibrions” from 
cholera patient in 1885 because of their motility. Vibrios are Gram-negative, curved, rod-shaped bacteria that are 
natural inhabitants of the marine, fresh water, and estuarine environments (McLaughlin et al.,1995). The Centre 
for Disease Control (CDC) estimated that 8,028 Vibrio infections and 57 deaths occur annually in the United 
States. Transmission of Vibrio infections is primarily through the consumption of raw or undercooked shellfish 
or exposure of wounds to warm seawater (Levine et al. 1993).Vibrio parahaemolyticus, Vibrio vulnificus and 
non-01/ non-0139 Vibrio cholerae have been isolated from humans suffering non-cholera vibrio infections 
(vibriosis), usually associated with the consumption of raw or under cooked seafoods and intake of contaminated 
natural waters (Yam et al.2000). 
     The primary environmental variables influencing this occurrence of pathogenic Vibrios in streams are 
temperature and salinity (Lipp et al. 2002). The optimum temperature for growth of this organism is 37°C, with 
possibilities for growth ranging from 16 to 42°C (Borroto et al. 2000). Floods and droughts may affect not only 
the concentration of the bacterium in this environment, but also its survival, through the effect exerted by these 
environmental changes on salinity, sunlight, pH, and nutrient concentrations (Bouma, 2001). Vibrio cholerae has 
optimum pH of 8.5, salinity of 15%, inhibited at temperature below 15oC and killed at temperature of 65oC and 
above (Borroto et al. 2000). The mainstay of the case management of cholera is treatment of dehydration using 
Oral Rehydration Therapy (ORS) or IV fluids (Ringer lactate) and electrolytes (Sack et al. 2006). In cholera 
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management, antibiotic prophylaxis is usually not part of intervention but essential for disease treatment in 
severe cases. 
 
 However, Vibrio cholerae strains from endemic and outbreaks situation within the last decade revealed 
interesting patterns of antibiotic resistance to commonly used antimicrobial agents. (Coppo et al.1995). Eighty 
six strains of Vibrio cholerae O1 (79 Ogawa serotype and 7 Inaba serotype) from 1992 outbreak in Nigeria were 
less sensitive to ampicillin, penicillin, cloxacillin, cotrimoxazole, streptomycin, and tetracycline (Olukoya et 
al.1995). The 1995 study also described Vibrio cholerae strains with 4.5 kilobase to 150 kilobase plasmids 
specifying resistance to ampicillin, tetracycline, and trimethoprim (Olukoya et al.1995). In Nigeria, existing 
prevention and control strategies are multi-sectoral. Epidemic Preparedness and Response (EPR) approaches 
including registration of cases, case management and public health measures targeting personal hygiene and 
water treatment as well as emergency responses from both governmental and non-government agencies have 
contributed to the reduction in case fatality rates over the years and should be sustained. Nevertheless, the need 
to explore more viable approaches cannot be overplayed if the infection has to be wholly curtailed. Due to its 
endemicity in Nigeria, surveillance systems can provide early alerts to outbreaks, therefore leading to 
coordinated response.  
 
More importantly, it is necessary to introduce intervention measures that address the root problems of poor 
sanitation and unsafe water supplies in order to prevent future cholera epidemics. In this regards, perhaps, 
prevention of the disease is the best way to counter subsequent outbreaks. Simple measures as boiling the water 
for drinking, washing and cooking purposes, treatment of infected facilities, sewages and drainage systems, 
proper disposal of infected materials such as waste products, clothing, and beddings, treatment of infected faecal 
waste water produced by cholera victims and sterilisation of utensils either by boiling or by using chlorine 
bleach. Studies have also indicated that use of soap and hand washing promotion can achieve a 26 to 62% 
decrease in the incidence of diarrhoea in developing countries (Bouma, 2001). 
 
Early detection and initiation of treatment of these infections are very important, particularly for cholera and 
invasive Vibrio infections, because these may rapidly progress to death (Vollberg and Herrara, 1997). Prevention 
of Vibrio infections requires a heightened awareness of these infections by clinicians, laboratory technicians, and 
epidemiologists. There are at least pathogenic Vibrio species recognized to cause human illness (Janda et al. 
1998). The Vibrio species of most medical significance include: Vibrio cholerae, Vibrio vulnificus, and Vibrio 
parahaemolyticus. 
 
Many researchers have studied different ways of controlling Vibrio cholerae infections using vaccine. Many 
researchers have stated that cholera vaccine areabout 85% effective during the first six monthsand 50–60% 
effective during the first year. The effectiveness decreases to less than50% after two years. When a significant 
portionof the population is immunized benefits fromherd immunity may occur among those not 
immunized.(Besser et al. 2005) also reported that no cholera vaccine is currently licensed and available for use 
by overseas travellers. The previously licensed vaccine in the United States was only about 50% effective and 
provided only 3 to 6 months of protection. Newer recombinant DNA vaccines like whole cell/recombinant B-
subunit (WC/rBS) have demonstrated protection for more than 1 year. At the moment, neither the CDC nor the 
WHO recommends routine use of the cholera vaccine for travellers, since it may create a false sense of security 
and does not affect cholera severity. From the studies, there were no effective vaccine control regimens that have 
been designed in order to control this menace infection. Therefore this work has been designed to try other 
measures of controlling Vibrio cholerae. 
 
MATERIALS AND METHODS 
Area of study: The study was conducted in Aruolah and Ubahudara streams at Uli, Ihiala L.G.A., Anambra 
State. Within the location of the streams, the major anthropological activities are domestic works. 
Sample Collection: The containers used for sample collection were washed with detergent and water, and was 
thoroughly rinsed with water and sterilized with 70% ethanol. Thecontainers were inverted on a swabbed bench, 
allowing the tiny droplets in the containers to dry up, and were aseptically closed.  Water sample were collected 
by lowering the plastic container inside the water body, 30 cm deep, allowed to overflow before withdrawing the 
container. The sampling points were approximately 100 mm away from one another. The samplings were done 
in triplicate. After collection, the sample were covered and placed in a cooler containing ice block to maintain 
the temperature during transportation for laboratory analysis. 
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Isolation and identification of the Vibrio cholerae: This was carried out by aseptically inoculating 1.0 ml of 
the sample on Thiosulphate citrate bile salt sucrose (Biotech) agar, using pour plate method and incubated at 
37°C for 48 h. After 48 h incubation the grown colonies were sub-cultured, characterized and identified using 
their colony descriptions, morphological and biochemical characteristics (Arora and Arora, 2008). 
Experimental Mice: A total of twenty (24) mice of mixed sex obtained from animal keeping house at Nnobi, 
Anambra State were used for this study. The mice were kept in separate, thoroughly cleaned and disinfected 
cages and provided with feeds and water ad libitum. 
Inoculation of the mice: This was carried out using the method of Iheukwumere et al. (2017). Broth culture of 
the isolate was centrifuged at 3000 r.p.m for 10 minutes. The sediment was diluted with sterile phosphate buffer 
saline (PBS) and adjusted to the 108CFu/ml using McFarland matching Standard. Then the mice (six in number) 
were inoculated orally with 0.5 ml of the inoculums while the control group (six in numbers) were only given 
distilled water. The infected mice were carefully observed for the clinical manifestation of the organism for a 
period of 4 weeks. The number of deaths was also observed. After 4 weeks, some of the infected mice sacrificed 
and gross examination of internal organs morphologies was carried out. 
Re-isolation of the organism from the infected organs: The internal organs of the infected mice were 
harvested and portions were aseptically macerated in peptone water and serial diluted using ten-fold serial 
dilution. Samples were inoculated into peptone water, incubated at 37oC for 24 h (Iheukwumere et al., 2017). 
Histopathological Study: This was carried out using the modified method of Iheukwumereet al.(2017). This 
study was done in Animal PathologyDepartment, University of Nigeria, Nsukka. After 4 weeks, the mice were 
autopsied. The internal organs were removed, portion of these organs were washed with PBS and stored in 
formalin solution for histopathological examination. 
Protection of infected mice: This was carried out using the modified methods of Iheukwumere et al. (2017).   
Preparation of autogenous bacterin: This was carried out by the modified method of Iheukwumere et al. 
(2017). The isolate was grown on nutrient agar at 37oC for 24 h. Growth was harvested in normal saline and 
inactivated with 1% formol saline at room temperature for 24 h. Using 0.5 Macfarland matching tube, washed 
concentrate of inactivated bacterium was suspended in normal saline to contain 108Cfu/ml. The sterile 
autogenous bacterin was obtained by adding equal volume of incomplete Freund’s adjuvant to adjusted washed 
concentrate of inactivated bacterium and kept at refrigerator until when used. The autogenous bacterin was 
giving to the experimental mice at first day in dose of 0.2ml/mouse and boostered at a second dose at 7days in 
dose of 0.4ml/mouse. The autogenous bacterin in the two shots was giving subcutaneously through the 
abdominal cavity. 
Quality control tests on the prepared autogenous bacterin: The prepared autogenous bacterin was tested for 
purity, complete inactivation, sterility and safety. ThePurity test was done before inactivation of the isolate. It 
was done to confirm that the broth culture of the isolate did nit contaminated by other bacteria before 
inactivation. This was done by subculturing the broth culture into TCBS agar and incubated at 37oc for 24 h. The 
colony was Gram stained, examined and finally confirmed using unique biochemical reactions.Complete 
inactivation test was carried out to ensure that the isolate was completely inactivated. The TCBS agar was 
inoculated with the autogenous bacterin, incubated at 37oC for 48 h. No visible growth of the isolate was seen. In 
the Sterility test, the prepared autogenous bacterin was confirmed to be free from any fungal contaminants by 
inoculating it into Sabouraud Dextrose Agar (SDA) plate and incubated at room temperature for 7 days. In the 
Safety test, two mice were aseptically inoculated subcutaneously with a large dose of the prepared autogenous 
bacterin (ten-fold of the normal dose). The mice were observed daily for five (5) successive days for any signs of 
local reactions, clinical signs or deaths.  
Experimental design: The mice were grouped into three (3) groups which include group A and B. Each group 
contained total of six mice. The treatments to the group were as follows:In the first group(A), Blank Control 
(only distilled water) was given. The second group (B) contain autogenous bacterin, 0.2 ml/mouse for the first 
dose and boostered on the 7th day with 0.5ml/mouse. The third group were mice Infected without treatment; the 
experimental mice were then exposed to the isolate via oral route after 14 days. The mice were carefully 
monitored for a period of 2 weeks (Iheukwumere et al., 2017). 
Detection of the humoral immune response: Just before the first dose of the autogenous bacterin (zero hour), 
the mice were randomly selected and their blood were collected. Also just before the second booster dose, 
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another blood sample was also collected on 14th day. The blood samples were allowed to separate. The separated 
sera were used against the isolate for agglutination reaction and the antibody titer against the isolate was 
determined and recorded (Wafaa et al. 2012). 
Examination of protected mice: The protected mice were carefully observed for the clinical manifestation of 
the inoculated organism for period of 2 weeks, the protection rates of the inhibitory substances were determined, 
and the mice were sacrificed and gross examination of the morphologies of internal organs and intestine were 
carried out. Also the internal organs were harvested and some portions of these organs were cultured on TCBS 
agar, and incubated at 37oC for 48 h. The counts were taken and the colonies were identified morphologically 
and biochemically (Wafaa et al.2012). The remaining portions of the organs were subjected to histopathological 
examination (Iheukwumere et al., 2017). 
Statistical Analysis: The data generated from this study were represented as mean ±Standard deviation and then 
charts. The test for significance at 95% confidence interval was carried out using ANOVA (Iheukwumere et al., 
2017) 
RESULTS 
Vibrio cholera was characterized and identified using its morphology, colony description and biochemical 
reactions(Table1). The isolate agglutinates fowl RBCS, haemolyse sheep RBCS and tested positive to catalase 
test, oxidase test, nitrosoindole test, string test, Vp test, glucose test, Sucrose test, arabinose test, saccharose test, 
citrate test, and motility test. The prevalence of Vibrio cholera in water samples collected from two major 
streams used in Uli community is shown in Table 2. The result of the present study revealed that Vibrio cholerae 
was significantly (P ˃ 0.05) seen more in water samples collected from Ubahudara stream as compared to water 
samples from Aruolah stream. The gross morphologies of the internal organs and intestines of the infected mice 
are shown in Table 3. Vibrio cholerae caused fluid accumulation in the intestine, hypertrophy of the liver and 
kidney, liver and kidney congestion, perihepatitis and death of some mice. The mean growth counts of Vibrio 
cholerae from the internal organs of the infected mice is shown in Table 4. The mean growth of Vibrio cholerae 
is significantly (P ˃ 0.05) seen most in the lungs, followed by the spleens and liver shows the least count. No 
Vibrio cholerae was isolated from the internal organs of the control mice.Table 5 shows the micro-agglutination 
antibody titers in the sera of mice after vaccination with locally prepared autogenous bacterin against Vibrio 
cholerae. There was no agglutination observed at day 0, before first autogenous bacterin dose. A maximum of 80 
titer value was observed in the sera of two mice before booster autogenous bacterin dose, while a maximum of 
160 titer value was observed in the sera of three mice before infection. No agglutination was recorded among the 
control mice before first autogenous bacterin dose, before booster autogenous bacterin dose and before infection. 
The gross morphological examination of the internal organs of protected mice against Vibrio cholerae is shown 
in Table 6.There was hypertrophy of the liver and Liver congestion in the mice protected with autogenous 
bacterin. The result of re-isolation of the Vibrio cholerae from the internal organs of protected mice is shown in 
Table 7. Seventy-seven colonies of the organism were re-isolated from positive control liver, one hundred and 
twenty-four from the lungs, forty-two and one hundred and five from the spleen. Nineteen and twenty-six were 
re-isolated from the kidney and spleen of those protected with autogenous bacterin respectively. Percent-Organ 
body weight ratio of the protected mice is shown in Table 8.There is a high Percent-Organ body weight ratio of 
the organs of control mice compared to the organs of mice protected with autogenous bacterin. 
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Table 1:  Characteristic and identity of Vibrio cholerae 
Parameter  Vibrio cholerae 
Appearance on TCBS Agar Yellow colonies 
Elevation Convex 
Size (mm) Entire  
Gram Reaction _ 
Shape  Comma shaped (Vibrio) 
Catalase  + 
Oxidase  + 
Nitrosoindole test + 
String test + 
Agglutination with Fowl RBCS + 
VP test + 
Glucose + 
Sucrose  + 
Arabinose _ 
Saccharose + 
Citrate  + 
Motility  + 
 
Table 2: Prevalence of Vibrio cholerae in water samples collected from two major streams used in      Uli 
Streams                                            Total Isolate Percentage% 
 
 
A 29 67.44 
B             14                         32.56 
Total             43                                        100 
A= Ubahudara stream  
B= Aruolah stream. 
 
Table 3: Gross morphologies of the internal organs and intestines of the infected mice                   
 
 
Parameter  Observation  
Haemorrhage of the liver Absent  
Haemorrhage of the lungs Absent 
Haemorrhage of the kidney Absent 
Haemorrhage of the heart Absent 
Fluid accumulation in the intestine Present 
Hypertrophy of the liver Present 
Hypertrophy of the kidney  Present 
Liver congestion Present 
Kidney congestion Present 
Pericarditis  Absent 
Perihepatitis Present 
Death  Present 
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Table 4: Mean growth of Vibrio choleraefrom the infected organs 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Microagglutination antibody titers in the sera of mice after vaccination  
with locally prepared autogenous bacterin against V.cholerae 
BFBD-Before First Autogenous bacterin Dose, BBBD-Before Booster Autogenous bacterin Dose, BI-Before 
Infection 
 
Organs  
 
Test 
 
 
Control 
Liver 77 — 
Lungs 124 — 
Kidney 42 — 
Spleen 105 — 
Isolate  Day  Interval 
 
Total   
 
 
0 
 
 
 
20 
 
 
 
40 
 
 
 
80 
 
 
 
160 
 
 
 
320 
 
 
 
640 
Vibrio cholerae 0 BFBD 6 6 0 0 0 0 0 0 
 7 BBBD 6 0 0 4 2 0 0 0 
 7 BI 6 0 0 0 0 2 1 3 
           
Control 0 BFBD 6 6 0 0 0 0 0 0 
 7 BBBD 6 6 0 0 0 0 0 0 
 7 BI 6 6 0 0 0 0 0 0 
Vibrio cholera counts (CFu/g) 
 
Antibody titerof the mice serum at different dilutions dilutions 
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Table 6: Gross morphological examination of the internal organs of protected  
mice against Vibrio cholerae 
Parameter   
 
F2 
 
 
A 
 
 
F1 
 
 
 
Haemorrhage of the liver  
— 
 
— 
 
— 
Haemorrhage of the lungs  
— 
 
— 
 
— 
Haemorrhage of the 
kidney 
 
— 
 
— 
 
— 
Haemorrhage of the heart  
— 
 
— 
 
— 
Fluid accumulation in the 
intestine 
 
— 
 
— 
 
+++ 
Hypertrophy of the liver  
— 
 
+ 
 
+++ 
Hypertrophy of the kidney  
— 
 
— 
 
— 
Kidney congestion  — — + 
Liver congestion — + +++ 
Pericarditis — — — 
Perihepatitis — — +++ 
Death  — — ++ 
A=Autogenous bacterin, +++ = High , ++   = Moderate, +     = Mild, F1      = Positive control (Infected mice 
without protection), F2    = Negative control (Healthy mice) 
 
Table 7:Re-isolation of the Vibrio cholerae from the internal organ of protected mice 
Organ                                                 Total mean count(Cfu/g)×102 
 
                                                A                                  F1                                               F2 
 
Liver                                   -                                        77                                        - 
Lungs                                  -                                            124                 - 
Kidney          19          42                                - 
Spleen          26         105                               - 
  
 
A= Autogenous bacterin, F1=Positive control, F2=Negative control 
 
Table 8: Percent-Organ body weight ratio of the protected mice 
Organ   
A 
 
F1 
 
F2 
Liver  0.048 0.081 0.042 
Lungs  0.026 0.043 0.018 
Kidney  0.010 0.019 0.007 
Spleen  0.003 0.007 0.001 
A     = Autogenous bacterin, F1       = Positive control, F2 = Negative control 
Observation 
Percent-Organ body weight Ratio (%) 
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DISCUSSION 
Biochemical reactions, morphological examination and colony description of Vibrio cholerae isolated in the 
study collaborates with the report of Basu, (2000), who worked on biochemical tests for Vibrio cholerae. Similar 
conclusion was drawn by (Besser et al.,2005).The variation in Vibrio cholerae loads among the two streams 
could be attributed to the fact that Ubahudara stream is more close to human settlement and more 
anthropological activities takes place in this stream than Aruolah stream. Similar conclusions were drawn by 
Faruque et al.(2000). Wenjing (2000) also reported that most drinking water contamination can be attributed to 
human activities.The accumulation of fluid in the intestines collaborates with the report of Muanprasat et 
al.(2012). The gross morphological examination of internal organ of infected mice against Vibrio cholerae 
revealed congestion in liver and kidney. This agrees with the report of Basu (2000). Oliver et al., (2007) also 
reported the death of mice associated with systemic spread of infection caused by choleragen toxin released by 
Vibrio cholerae. The significant growth of Vibrio cholerae observed from the internal organs of infected mice 
showed that the organism was able to invade and multiply in these organs. Similar result was reported by Basu, 
(2000). In the present study, significant antibiodies produced by vaccinated mice before booster autogenous 
bacterin dose (BBBD) and before infection (BI) agree with the report of Hlady and Klontz (2003). The antibody 
was able to offer little protection to the mice.The result of the gross morphological examination of the internal 
organs of protected mice against Vibrio cholerae revealed the hypertrophy of the liver and liver congestion. This 
could be due to the production of hemolysin-cytolysin toxin as a result of choleragen toxin activation. These 
agree with the report of Oliver (2007), who worked on systemic spread of infection caused by choleragen toxin 
released by Vibrio cholerae. The low count of Vibrio cholerae associated with the internal organs of protected 
mice after infection shows that autogenous bacterin was able to protect the organs against the invading organism 
(Colwell et al. 1996). Autogenous bacterin offered a promising protection on the mice against Vibrio cholerae 
and this could be due to production of antibody against Vibrio cholerae. The slight increase in percent-organ 
body weight ratio of the protected mice when compared with that of negative control could be attributed to the 
side effect caused by the autogenous bacterin.( Oliver, 2007). 
CONCLUSION 
The study revealed the effect of autogenous bacterin on Vibrio cholerae. It can also be stated that this 
autogenous bacterin can be used in the treatment of Vibrio infection for short term since it offered a promising 
protection on the mice against its causative agent, Vibrio cholerae.   
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